Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADL5859 for Pain After Third Molar Extraction
NCT00993863Phase 2Completed
- Sponsor
- Merck & Co.
- Start
- Jun 2007
- Primary completion
- Sep 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of ADL5859 in odontalgia (5 arms), sponsored by Merck & Co. Primary endpoint: Total pain relief 0-4 hours after study medication. Started Jun 2007; status: completed.
02
Drugs
ADL5859
03
Conditions
odontalgia
Beyond the preview
Go deeper on NCT00993863.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00993863.